- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Cerca studi clinici per: iobenguane
Totale 34 risultati
-
Jubilant DraxImage Inc.ReclutamentoNeoplasie | Tumori neuroectodermici | NeuroblastomaStati Uniti
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)ReclutamentoNeuroblastoma | FeocromocitomaStati Uniti
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Progenics...RitiratoTumori neuroendocrini | Tumore neuroendocrino gastro-enteropancreaticoStati Uniti
-
Children's Oncology GroupNational Cancer Institute (NCI)Attivo, non reclutanteNeuroblastoma | GanglioneuroblastomaStati Uniti, Canada, Porto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)Attivo, non reclutanteNeuroblastoma resecabile localizzato | Neuroblastoma localizzato non resecabile | Neuroblastoma regionale | Neuroblastoma in stadio 4S | Ganglioneuroblastoma | Stadio 4 NeuroblastomaStati Uniti
-
Children's Oncology GroupNational Cancer Institute (NCI)Attivo, non reclutanteNeuroblastoma | Ganglioneuroblastoma, nodulareStati Uniti, Australia, Canada, Nuova Zelanda
-
Children's Hospital Los AngelesNational Cancer Institute (NCI)Completato
-
New Approaches to Neuroblastoma Therapy ConsortiumUnited TherapeuticsAttivo, non reclutante
-
Children's Hospital Medical Center, CincinnatiNon più disponibileNeuroblastoma | Feocromocitoma | ParagangliomaStati Uniti
-
Northwell HealthCohen Children's Medical CenterA disposizioneNeuroblastoma | FeocromocitomaStati Uniti
-
Children's Hospital Los AngelesNational Cancer Institute (NCI)CompletatoNeuroblastomaCanada, Stati Uniti
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)CompletatoNeuroblastomaStati Uniti
-
Jubilant DraxImage Inc.A disposizioneNeuroblastoma | Feocromocitoma | ParagangliomaStati Uniti
-
New Approaches to Neuroblastoma Therapy ConsortiumCompletatoNeuroblastomaStati Uniti, Canada
-
Molecular Insight Pharmaceuticals, Inc.SconosciutoFeocromocitoma | ParagangliomaStati Uniti
-
GE HealthcareCompletatoNeuroblastoma | FeocromocitomaStati Uniti
-
GE HealthcareABX CRO; H2O Clinical LLC; TransPerfect; Advanced Clinical, LLC; TFS; AG Mednet Inc.; ICON... e altri collaboratoriTerminatoArresto cardiacoStati Uniti, Spagna, Canada, Francia, Olanda, Polonia, Cechia, Italia, Germania, Ungheria
-
Molecular Insight Pharmaceuticals, Inc.Approvato per il marketingFeocromocitoma | ParagangliomaStati Uniti
-
GE HealthcareCompletatoInsufficienza cardiaca, congestiziaStati Uniti
-
Molecular Insight Pharmaceuticals, Inc.Completato
-
GE HealthcareCompletatoInsufficienza cardiaca, congestiziaStati Uniti
-
GE HealthcareQuintiles, Inc.; H2O Clinical LLCCompletatoDisfunzione ventricolare, sinistra | Insufficienza cardiaca (HF)Stati Uniti
-
Centre Oscar LambretNovartis Pharmaceuticals; National Cancer Institute, FranceCompletato
-
Molecular Insight Pharmaceuticals, Inc.CompletatoFeocromocitoma | ParagangliomaStati Uniti
-
Molecular Insight Pharmaceuticals, Inc.RitiratoNeuroblastomaStati Uniti, Canada
-
Gesellschaft fur Padiatrische Onkologie und Hamatologie...Sconosciuto
-
Topica PharmaceuticalsCompletato
-
University of California, San FranciscoNational Cancer Institute (NCI)Completato
-
Gesellschaft fur Padiatrische Onkologie und Hamatologie...Sconosciuto
-
Bennett ChinNational Cancer Institute (NCI); Molecular Insights PharmaceuticalsCompletatoArresto cardiaco | Tumori neuroendocriniStati Uniti
-
Molecular Insight Pharmaceuticals, Inc.CompletatoFeocromocitoma | Paraganglioma | Carcinoide
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)Completato
-
Children's Hospital Los AngelesNational Cancer Institute (NCI)Completato
-
GE HealthcareApprovato per il marketingNeuroblastomaStati Uniti